Efficacy of darbepoetin alfa in chemotherapy-induced anemia in gastrointestinal cancers.

被引：0
|
作者：
Blayney, D
Vadhan-Raj, S
Tomita, D
Rossi, G
Mirtsching, B
机构：
[1] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Ctr Oncol Res & Treatment, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：781S / 781S
页数：1
相关论文
共 50 条
  • [31] Darbepoetin alfa as a treatment for chemotherapy-induced anemia: An integrated analysis of data from multiple studies
    Hedenus, M
    Vansteenkiste, J
    Poulsen, E
    Rossi, G
    Glapsy, J
    BLOOD, 2002, 100 (11) : 17B - 18B
  • [32] Darbepoetin alfa dosed every 3 weeks in chemotherapy-induced anemia in patients with lung cancer
    Barata, F
    Parente, B
    Teixeira, E
    Barroso, A
    Figueiredo, A
    Conde, S
    LUNG CANCER, 2005, 49 : S331 - S331
  • [33] Effectiveness of darbepoetin alfa administered every three weeks to elderly patients with chemotherapy-induced anemia
    Gasent, J. M.
    Bermejo, J. C., II
    Lopez, P.
    Domenech, M.
    Sanchez-Rovira, P.
    Villadiego, K.
    de Pedro, C.
    Iturralde, P.
    Gasquet, J. A.
    Rodriguez, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
  • [35] Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia
    Boccia, Ralph V.
    Henry, David H.
    Belton, Laura
    Bohac, Chet
    Ghazal, Hassan H.
    CANCER MEDICINE, 2016, 5 (12): : 3445 - 3453
  • [36] DOSING PATTERN AND COST COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA INPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A161 - A161
  • [37] Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia
    Vansteenkiste, J
    Rossi, G
    Foote, M
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (03) : 501 - 508
  • [38] Darbepoetin alfa administered once every three weeks is effective for treating chemotherapy-induced anemia.
    Canon, JL
    Bodoky, G
    Mateos, MV
    Bastit, L
    Ferreira, I
    Amado, R
    Vansteenkiste, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S216 - S216
  • [39] Clinical trial simulation of a 200-μg fixed dose of darbepoetin alfa in chemotherapy-induced anemia
    Jumbe, N
    Yao, B
    Rovetti, R
    Rossi, G
    Heatherington, AC
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 37 - 44
  • [40] Efficacy of Darbepoetin alfa in Anemia Developed during Chemotherapy for Lung Cancer
    Ban, Hee-Jung
    Chi, Su-Young
    Park, Cheol-Kyu
    Kim, Eun-Young
    Kim, Yoon-Hee
    Kim, Kyu-Sik
    Ju, Jin-Young
    Kwon, Yong-Soo
    Oh, In-Jae
    Kim, Yu-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (02) : 104 - 109
12345